drugset / Trial / NCT06951256

Dexmedetomidine as an Adjuvant to Bupivacaine in Scalp Block vs Bupivacaine Alone for Hemodynamics Stability in Craniotomy

NCT06951256 ↗

Completed 36 enrolled Ain Shams University
RandomizedParallel-groupDouble-blindOther

Summary

The investigator tested the effect of dexmedetomidine as an adjuvant to bupivacaine compared to bupivacaine alone in mean arterial pressure stability in adult patients undergoing craniotomy

Timeline

Start
2024-03-10
Primary completion
2024-09-10
Completion
2024-09-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 1 ug/kg Other
Comparator Bupivacaine Other / unclassified 0.25 % Other

Indications

No indication recorded.